Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

47.02
-0.6000-1.26%
Volume:9.87M
Turnover:464.42M
Market Cap:95.69B
PE:17.61
High:47.40
Open:47.19
Low:46.52
Close:47.62
Loading ...

U.S. Food and Drug Administration Approves Opdivo® (Nivolumab) Plus Yervoy® (Ipilimumab) as a Treatment for Patients With Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer1

THOMSON REUTERS
·
09 Apr

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer1

Business Wire
·
09 Apr

Bristol-Myers Lands FDA Approval for Combination Treatment of Colorectal Cancer

MT Newswires Live
·
09 Apr

BRIEF-FDA Approves Nivolumab With Ipilimumab For Unresectable Or Metastatic MSI-H Or dMMR Colorectal Cancer

Reuters
·
09 Apr

FDA approves nivolumab with ipilimumab for additional indication

TIPRANKS
·
09 Apr

FDA Approves Nivolumab With Ipilimumab for Unresectable or Metastatic Msi-H or Dmmr Colorectal Cancer

THOMSON REUTERS
·
09 Apr

Bristol-Myers Squibb Cut to Neutral From Buy by Goldman Sachs

Dow Jones
·
09 Apr

Goldman turns cautious on major pharma names, sees select upside at Eli Lilly

Investing.com
·
08 Apr

Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
05 Apr

Bristol Myers Squibb call volume above normal and directionally bullish

TIPRANKS
·
04 Apr

Healthcare Stocks Are Steady Amid Tariff Rout. Stay Alert for Danger Ahead. -- Barrons.com

Dow Jones
·
04 Apr

The Zacks Analyst Blog Highlights Exxon Mobil, Bristol-Myers Squibb, Chubb and Hamilton Beach Brands

Zacks
·
03 Apr

Pharma Stocks Aren't in the Clear, Despite Tariff Exemption-Heard on the Street -- WSJ

Dow Jones
·
03 Apr

Bernstein Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)

TIPRANKS
·
03 Apr

BUZZ-US drugmakers fall after Trump announces reciprocal tariffs

Reuters
·
03 Apr

Top Research Reports for Exxon Mobil, Bristol-Myers Squibb & Chubb

Zacks
·
03 Apr

Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More

Zacks
·
03 Apr

Drug Industry Offers Tepid Pushback to Kennedy's FDA Job Cuts -- Barrons.com

Dow Jones
·
02 Apr

Is Bristol Myers Squibb's High-Yielding Dividend Safe?

Motley Fool
·
02 Apr

RBC Canadian Equity Income Fund's Strategic Move: Alimentation Couche-Tard Inc. Takes Center Stage

GuruFocus.com
·
02 Apr